Update on different aspects of HCV variability: Focus on NS5B polymerase

BMC Infectious Diseases

Volumn 14, Issue , 2014, Pages

  Marascio, Nadia ^a   Torti, Carlo ^a,b   Liberto, Maria Carla ^a   Focà, Alfredo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GENOMIC RNA; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NONSTRUCTURAL PROTEIN 5B; NONSTRUCTURAL PROTEIN 5B POLYMERASE; NUCLEOSIDE ANALOG; UNCLASSIFIED DRUG;

DISEASE CLASSIFICATION; GENETIC CODE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; PATHOGENESIS; PHYLOGENY; PREVALENCE; REVIEW; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

EID: 84906832237     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-S5-S1     Document Type: Review

References (44)

1. Simmonds P, Holmes E C, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993, 74:2391-2399. 10.1099/0022-1317-74-11-2391, 8245854.
2. Simmonds P, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe´ G, Kuiken C, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005, 42:962-973. 10.1002/hep.20819, 16149085.
3. Simmonds P. The origin of hepatitis C virus. Curr Top Microbiol Immunol 2013, 369:1-15.
4. European Association of the Study of the Liver 2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines. Liver Int 2012, 32(Suppl 1):2-8. European Association of the Study of the Liver.
5. Pollicita M, Cento V, Paba P, Perno CF, Ciotti M. Nucleotide polymorphisms in the 5'-UTR region of HCV can affect the ability of two widely used assays to assign an HCV genotype. J Virol Methods 2013, 193(1):205-208. 10.1016/j.jviromet.2013.06.002, 23791962.
6. Gonza´lez V, Gomes-Fernandes M, Bascuñana E, Casanovas S, Saludes V, Jordana-Lluch E, Matas L, Ausina V, Martro´ E. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J Clin Virol 2013, 58(1):249-253. 10.1016/j.jcv.2013.05.005, 23731847.
7. Lampe E, Lewis-Ximenez L, Espi´rito-Santo MP, Delvaux NM, Pereira SA, Peres-da-Silva A, Martins RM, Soares MA, Santos AF, Vidal LL, Germano FN, de Martinez AM, Basso R, Pinho JR, Malta FM, Gomes-Gouveˆa M, Moliterno RA, Bertolini DA, Fujishima MA, Bello G. Genetic diversity of HCV in Brazil. Antivir Ther 2013, 18(3 Pt B):435-444. 10.3851/IMP2606, 23792792.
8. Ciccozzi M, Equestre M, Costantino A, Marascio N, Quirino A, Lo Presti A, Cella E, Bruni R, Liberto MC, Foca` A, Pisani G, Zehender G, Ciccaglione AR. Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol 2012, 84(10):1613-1619. 10.1002/jmv.23384, 22930510.
9. Re´ VE, Culasso ACA, Mengarelli S, Fari{dotless}as AA, Fay F, Pisano MB, Elbarcha O, Contigiani MS, Campos RH. Phylodynamics of Hepatitis C Virus Subtype 2c in the Province of Cordoba, Argentina. PLoS ONE 2011, 6(5):e19471. 10.1371/journal.pone.0019471, 3097208, 21611129.
10. Kapoor A, Simmonds P, Scheel TKH, Hjelle B, Cullen JM, Burbelo PD, Chauhan LV, Duraisamy R, Sanchez Leon M, Jain K, Vandegrift KJ, Calisher CH, Rice CM, Lipkin WI. Identification of rodent homologs of hepatitis C virus and pegiviruses. mBio 2013, 4(2):e00216-13. 3622934, 23572554.
11. Jacka B, Lamoury F, Simmonds P, Dore GJ, Grebely J, Applegate T. Sequencing of the Hepatitis C Virus: A Systematic Review. PLoS ONE 2013, 8(6):e67073. 10.1371/journal.pone.0067073, 3694929, 23826196.
12. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990, 170(3):1021-1025. 10.1016/0006-291X(90)90494-8, 2117923.
13. Jaspe RC, Sulbara´n YF, Sulbara´n MZ, Loureiro CL, Rangel HR, Pujol FH. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates. Virol J 2012, 9:214. 10.1186/1743-422X-9-214, 3511240, 22995142.
14. Moradpour D, Penin F. Hepatitis C virus proteins: from structure to function. Curr Top Microbiol Immunol 2013, 369:113-142.
15. Lohmann V. Hepatitis C virus RNA replication. Curr Top Microbiol Immunol 2013, 369:167-198.
16. Harrus D, Ahmed-El-Sayed N, Simister PC, Miller S, Triconnet M, Hagedorn CH, Mahias K, Rey FA, Astier-Gin T, Bressanelli S. Further insights into the roles of GTP and the C terminus of the hepatitis C virus polymerase in the initiation of RNA synthesis. J Biol Chem 2010, 285(43):32906-32918. 10.1074/jbc.M110.151316, 2963421, 20729191.
17. Ferraris P, Blanchard E, Roingeard P. Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes. J Gen Virol 2010, 91(Pt 9):2230-2237.
18. Romero-Brey I, Merz A, Chiramel A, Lee J-Y, Chlanda P, Haselman U, Santarella-Mellwig R, Habermann A, Hoppe S, Kallis S, Walther P, Antony C, Krijnse-Locker J, Bartenschlager R. Three-Dimensional Architecture and Biogenesis of Membrane Structures Associated with Hepatitis C Virus Replication. PLoS Pathog 2012, 8(12):e1003056. 10.1371/journal.ppat.1003056, 3516559, 23236278.
19. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, Matula P, Kaderali L, Poenisch M, Blankenburg H, Hiet MS, Longerich T, Diehl S, Ramirez F, Balla T, Rohr K, Kaul A, Bu¨hler S, Pepperkok R, Lengauer T, Albrecht M, Eils R, Schirmacher P, Lohmann V, and Bartenschlager R. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 2011, 9(1):32-45. 10.1016/j.chom.2010.12.002, 3433060, 21238945.
20. Berger KL, Kelly SM, Jordan TX, Tartell MA, and Randall G. Hepatitis C Virus Stimulates the Phosphatidylinositol 4-Kinase III Alpha-Dependent Phosphatidylinositol 4-Phosphate Production That Is Essential for Its Replication. J Virol 2011, 85:8870-8883. 10.1128/JVI.00059-11, 3165839, 21697487.
21. Tang H, Grise´ H. Cellular and molecular biology of HCV infection and hepatitis. Clin Sci (Lond) 2009, 117(2):49-65. 10.1042/CS20080631, 19515018.
22. Upadhyay A, Dixit U, Manvar D, Chaturvedi N, Pandey VN. Affinity capture and identification of host cell factors associated with hepatitis C virus (+) strand subgenomic RNA. Mol Cell Proteomics 2013, 12(6):1539-1552. 10.1074/mcp.M112.017020, 3675812, 23429521.
23. Steinmann E, Pietschmann T. Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol 2013, 369:17-48.
24. Wahyuni TS, Tumewu L, Permanasari AA, Apriani E, Adianti M, Rahman A, Widyawaruyanti A, Lusida MI, Fuad A, Soetjipto D, Nasronudin D, Fuchino H, Kawahara N, Shoji I, Deng L, Aoki C, Hotta H. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus. Virol J 2013, 10(1):259. 10.1186/1743-422X-10-259, 3751543, 24089993.
25. Gouklani H, Bull RA, Beyer C, Coulibaly F, Gowans EJ, Drummer HE, Netter HJ, White PA, Haqshenas G. Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. J Virol 2012, 86(9):5080-5088. 10.1128/JVI.07089-11, 3347352, 22345449.
26. World Health Organization: Guidelines for the screening, care and treatment of persons with hepatitis C infection. 2014, http://www.who.int
27. Soriano V, Vispo E, de Mendoza C, Labarga P, Fernandez-Montero JV, Poveda E, Treviño A, Barreiro P. Hepatitis C therapy with HCV NS5B polymerase inhibitors. Expert Opin Pharmacother 2013, 14(9):1161-1170. 10.1517/14656566.2013.795543, 23621117.
28. Kylefjord H, Danielsson A, Sedig S, Belda O, Wiktelius D, Vrang L, Targett-Adams P. Transient replication of a hepatitis C virus genotype 1b replicon chimera encoding NS5A-5B from genotype 3a. J Virol Methods 2013,
29. Figlerowicz M, Jackowiak P, Formanowicz P, Kedziora P, Alejska M, Malinowska N, Błazewicz J, Figlerowicz M. Hepatitis C virus quasispecies in chronically infected children subjected to interferon-ribavirin therapy. Arch Virol 2010, 155:1977-1987. 10.1007/s00705-010-0789-7, 2982956, 20842394.
30. Shi W, Freitas IT, Zhu C, Zheng W, Hall WW, Higgins DG. Recombination in Hepatitis C Virus: Identification of Four Novel Naturally Occurring Inter- Subtype Recombinants. PLoS ONE 2012, 7(7):e41997. 10.1371/journal.pone.0041997, 3404033, 22911872.
31. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002, 76(8):4034-4043. 10.1128/JVI.76.8.4034-4043.2002, 136067, 11907242.
32. Gonza´lez-Candelas F, Lo´pez-Labrador FX, Bracho MA. Recombination in Hepatitis C Virus. Viruses 2011, 3:2006-2024. 10.3390/v3102006, 3205392, 22069526.
33. Di Maio VC, Cento V, Mirabelli C, Artese A, Costa G, Alcaro S, Perno CF, Ceccherini-Silberstein F. Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors. Antimicrob Agents Chemother 2014, 58(5):2781-2797. 10.1128/AAC.02386-13, 24590484.
34. Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman KE. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol 2010, 48(11):4256-4259. 10.1128/JCM.01613-10, 3020841, 20810773.
35. Le Pogam S, Seshaadri A, Kosaka A, Chiu S, Kang H, Hu S, Rajyaguru S, Symons J, Cammack N, and Najera I. Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients. J Antimicrob Chemother 2008, 61:1205-1216. 10.1093/jac/dkn085, 18343801.
36. Markov PV, van de Laar TJ, Thomas XV, Aronson SJ, Weegink CJ, van den Berk GE, Prins M, Pybus OG, Schinkel J. Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. J Virol 2012, 86(14):7677-7687. 10.1128/JVI.06910-11, 3416291, 22573865.
37. Forbi JC, Purdy MA, Campo DS, Vaughan G, Dimitrova ZE, Ganova-Raeva LM, Xia GL, Khudyakov YE. Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa. J Gen Virol 2012, 93(7):1410-1421.
38. Kchouk FH, Gorgi Y, Bouslama L, Sfar I, Ayari R, Khiri H, Halfon P, Aouadi H, Jendoubi Ayed S, Ayed K, Ben Abdallah T. Phylogenetic analysis of isolated HCV strains from tunisian hemodialysis patients. Viral Immunol 2013, 26(1):40-48. 10.1089/vim.2012.0043, 3578366, 23374151.
39. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008, 48(1):148-162. 10.1016/j.jhep.2007.07.033, 18022726.
40. Larrat S, Poveda JD, Coudret C, Fusillier K, Magnat N, Signori-Schmuck A, Thibault V, Morand P. Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0. J Clin Microbiol 2013, 51(9):2815-2821. 10.1128/JCM.00586-13, 3754683, 23616453.
41. Richter SS. Laboratory assays for diagnosis and management of hepatitis C virus infection. J Clin Microbiol 2002, 40(12):4407-4412. 10.1128/JCM.40.12.4407-4412.2002, 154655, 12454127.
42. Du H, Qi Y, Hao F, Huang Y, Mao L, Ji S, Huang M, Qin C, Yan R, Zhu X, Zhang C. Complex patterns of HCV epidemic in Suzhou: evidence for dual infection and HCV recombination in East China. J Clin Virol 2012, 54(3):207-212. 10.1016/j.jcv.2012.04.017, 22595306.
43. Blackard JT, Ma G, Welge JA, Martin CM, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol 2012, 84(2):242-252. 10.1002/jmv.22269, 3243959, 22170544.
44. Pickett BE, Striker R, Lefkowitz EJ. Evidence for separation of HCV subtype 1a into two distinct clades. J Viral Hepat 2011, 18(9):608-618. 10.1111/j.1365-2893.2010.01342.x, 2964416, 20565573.